Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore to Continue Funding Founder's Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies announced an agreement today to continue funding research in Hagan Bayley's laboratory at Oxford University.

The company will partner exclusively with the university to develop "revolutionary products" for molecular analysis from the discoveries, Oxford Nanopore said in a statement.

Research projects at Bayley's lab include the development of methods for direct sequencing of single-stranded DNA.

Bayley is a professor of chemical biology at Oxford and the founder of Oxford Nanopore, originally called Oxford Nanolabs. The company also has been developing protein nanopore technology originally created by Bayley.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.